|
Q1 FY2019
As of Mar 31, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investment in mortgage loans, held for investment: | ||||||||||||||||||||
| Commercial mortgage loans, mezzanine loans, and preferred equity interests | ||||||||||||||||||||
| Allowance for loan losses | ||||||||||||||||||||
| Investment in mortgage loans | ||||||||||||||||||||
| Held For Investment | ||||||||||||||||||||
| Held For Sale | ||||||||||||||||||||
| Total investment in mortgage loans | ||||||||||||||||||||
| Investments in securities and security-related receivables, at fair value | ||||||||||||||||||||
| Investments in real estate, net of accumulated depreciation | ||||||||||||||||||||
| Investments in real estate, held for sale | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Intangible assets, net of accumulated amortization of $5,876 and $5,703, respectively | ||||||||||||||||||||
| Assets of discontinued operations (See Note 9) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Indebtedness, net of unamortized discounts, premiums and deferred financing costs of $16,033 and $16,643 respectively (including $390,675 and $440,776 held by consolidated VIEs, respectively) | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Deferred taxes, borrowers’ escrows and other liabilities | ||||||||||||||||||||
| Liabilities of discontinued operations (See Note 9) | ||||||||||||||||||||
| Borrowers' escrows | ||||||||||||||||||||
| Deferred taxes and other liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Series D cumulative redeemable preferred shares, $0.01 par value per share, 0 and 4,000,000 shares authorized, respectively, 0 and 3,133,720 shares issued and outstanding, respectively | ||||||||||||||||||||
| Preferred shares, $0.01 par value per share | ||||||||||||||||||||
| 7.75% Series A Cumulative Redeemable Preferred Stock | ||||||||||||||||||||
| 8.375% Series B Cumulative Redeemable Preferred Stock | ||||||||||||||||||||
| 8.875% Series C Cumulative Redeemable Preferred Stock | ||||||||||||||||||||
| Common shares, $1.50 par value per share, 200,000,000 shares authorized 1,849,530 and 1,850,451 issued and outstanding, respectively, including 4,997 and 6,844 unvested restricted common share awards, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Retained earnings (deficit) | ||||||||||||||||||||
| Shareholders' equity | ||||||||||||||||||||
| 7.75% Series A Cumulative Redeemable Preferred Stock | ||||||||||||||||||||
| 8.375% Series B Cumulative Redeemable Preferred Stock | ||||||||||||||||||||
| 8.875% Series C Cumulative Redeemable Preferred Stock | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Noncontrolling interests - continuing operations | ||||||||||||||||||||
| Noncontrolling interests - discontinued operations | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| 7.75% Series A Cumulative Redeemable Preferred Stock | ||||||||||||||||||||
| 8.375% Series B Cumulative Redeemable Preferred Stock | ||||||||||||||||||||
| 8.875% Series C Cumulative Redeemable Preferred Stock | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...